Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic use of anti-CD22 antibodies for inducing trogocytosis

Therapeutic use of anti-CD22 antibodies for inducing trogocytosis

US Patent 9963507 · Granted May 8, 2018

Estimated economic value: $24,126,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for hemoclip deployment2025
Tool for hemostasis and tissue approximation2025
Anti-glare layer and manufacturing method thereof2025
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and de2025
Antibody-drug conjugates and uses thereof2025
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and de2025
Display device2024
Reflective active device array substrate and manufacturing method thereof and re2024
Display apparatus2023
Display device2023
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and de2023
Synergistic effect of anti-trop-2 antibody-drug conjugate in combination therapy2022